Quantcast
Free Trial!
Today’s Best Stocks To Trade!  Click Here


 

BUYINS.NET: BZP, CTIB, GHDX, MHLD, NCTY, NETL Have Also Been Added To Naked Short List Today

Thu. July 17, 2008; Posted: 01:03 PM
Stocks RSS
Jul 17, 2008 (M2 PRESSWIRE via COMTEX) -- NCTY | Quote | Chart | News | PowerRating -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list: BPZ Resources Inc (AMEX: BZP), CTI Industries Corp. (NASDAQ: CTIB), Genomic Health Inc. (NASDAQ: GHDX), Maiden Hldgs Ltd (NASDAQ: MHLD), The9 Ltd. (NASDAQ: NCTY), NetLogic Microsystems Inc. (NASDAQ: NETL). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.

BPZ Resources Inc (AMEX: BZP | Quote | Chart | News | PowerRating) engages in the exploration, development, and production of oil and natural gas in Peru and Ecuador. It has rights and license agreements for oil and gas exploration and production covering approximately 2.4 million acres in northwest Peru. The company's license contracts cover 100% ownership of Block Z-1 covering 739,205 acres; Block XIX that comprises 472,860 acres; Block XXII covering 948,000 acres; and Block XXIII that comprises 248,000 acres. It also owns a 10% non-operating working interest in the Santa Elena property located in the southwest region of Ecuador, as well as focuses on the generation of electricity through its gas-fired power generation facility in Peru. The company was founded in 2001. It was formerly known as BPZ Energy, Inc. and changed its name to BPZ Resources, Inc. in 2007. BPZ Resources is headquartered in Houston, Texas with additional offices in Lima, Peru, and Quito, Ecuador. With 76.64 million shares outstanding and 7.45 million shares declared short as of July 2008, there is a failure to deliver in shares of BZP. According to quarterly data provided by the SEC, there were still 238,115 shares of BZP that were failing-to-deliver as of September 28, 2007.

CTI Industries Corp. (NASDAQ: CTIB | Quote | Chart | News | PowerRating) together with its subsidiaries, develops, produces, markets, and sells novelty products, specialty and printed films, and flexible containers. The company's products include metalized balloons, latex balloons, punch balls, and related latex toy products; films for packaging applications; and flexible containers for packaging and storage applications. It also operates systems for the production, lamination, coating, and printing of films used for food packaging and other commercial uses, as well as for conversion of films to flexible packaging containers and other products. The company sells its products through distributors, wholesalers, and independent sales representatives, as well as retail outlets, including general merchandise, discount and drugstore chains, grocery chains, card and gift shops, party goods stores, and florists and balloon decorators. It operates in the United States, Mexico, and the United Kingdom. CTI Industries Corporation was founded in 1975 and is headquartered in Barrington, Illinois. With 2.73 million shares outstanding and 27,700 shares declared short as of July 2008, there is a failure to deliver in shares of CTIB. According to quarterly data provided by the SEC, there were still 12,006 shares of CTIB that were failing-to-deliver as of September 13, 2007.

Genomic Health Inc. (NASDAQ: GHDX | Quote | Chart | News | PowerRating) a life science company, engages in the development and commercialization of genomic-based clinical diagnostic tests for cancer that enable physicians and patients to make individualized treatment decisions in the United States. The company's Oncotype DX is a clinical laboratory test, which is used for early stage breast cancer patients to predict the likelihood of cancer recurrence and the likelihood of chemotherapy benefit. It offers Oncotype DX as a clinical laboratory service, where it analyses the expression levels of 21 genes in tumor tissue samples in its laboratory and provide physicians with a quantitative gene expression profile expressed as a single quantitative Recurrence Score. The Oncotype DX report also includes measurements of quantitative gene expression for estrogen receptor (ER) and progesterone receptor (PR), which are used in the calculation of the Recurrence Score result. In addition, the company is in the early development phase to develop tests to predict the likelihood of response to the epidermal growth factor receptor inhibitor class of drugs, as well as for a product to predict the likelihood of taxane benefit in breast cancer patients. Further, it has products in various stages of development for other cancers, including colon cancer, prostate cancer, renal cell cancer, non-small cell lung cancer, and melanoma. The company has collaborative agreements with Aventis, Inc. and the Eastern Cooperative Oncology Group to investigate the ability of gene expression in FPE tissues to predict the likelihood of response to adjuvant chemotherapy, including the taxane Taxotere, in patients with early breast cancer and zero to three involved lymph nodes; and Bristol-Myers Squibb Company and ImClone Systems Incorporated to develop a genomic test to predict the likelihood of response to Erbitux in colorectal cancer. Genomic Health, Inc. was founded in 2000 and is based in Redwood City, California. With 28.25 million shares outstanding and 4.23 million shares declared short as of July 2008, there is a failure to deliver in shares of GHDX. According to quarterly data provided by the SEC, there were still 16,955 shares of GHDX that were failing-to-deliver as of September 21, 2007.

Maiden Hldgs Ltd (NASDAQ: MHLD | Quote | Chart | News | PowerRating) provides reinsurance business solutions to the property and casualty industry in the United States and Europe. It offers its products to AmTrust Financial Services, Inc. and its subsidiaries, as well as to small specialty property and casualty insurance companies. The company reinsures workers' compensation liabilities for small businesses, including restaurants, retail stores, physicians' and other professionals' offices, building management-operations by owner or contractor, private schools; hotels, light metal working machine shops, small grocery and specialty food stores, wholesale shops, and beauty shops. It also reinsures specialty middle-market property and casualty segment, which consists of workers' compensation, general liability, and commercial auto liability for small and middle-market businesses, such as retail, wholesale, service operations, artisan contracting, and light and medium manufacturing. In addition, the company reinsures specialty risk and extended warranty coverage, which provide coverage for accidental damage, mechanical breakdown, and related risks for consumer and commercial goods. Maiden Holdings, Ltd. was incorporated in May 2007 and is based is Hamilton, Bermuda. With 59.55 million shares outstanding and 29,200 shares declared short as of July 2008, there is a failure to deliver in shares of MHLD.

The9 Ltd. (NASDAQ: NCTY | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the development and operation of online games, and Internet and Web site related businesses in the People's Republic of China. It has licenses to operate various massively multiplayer online role playing games (MMORPGs), including WoW, a 3D MMORPG; MU, a 2.5D quarter-view MMORPG; Granado Espada, a 3D MMORPG; SUN, a 3D MMORPG; Hellgate: London, an action role-playing game; Joyful Journey West, a 2D MMORPG; Emil Chronicle Online, a 2.5D MMORPG; Ragnarok Online 2, a 3D MMORPG; Huxley, a 3D first-person shooting MMORPG; EA Sports FIFA Online, a casual soccer game; and Audition 2, a casual dancing game. The company also has a license to operate the Burning Crusade expansion pack for the WoW game. In addition, it offers other products and services, including The9 City, an online virtual community game; game operating support, Web site solutions, and advertisement services; short messaging services; and Pass9, a membership management and payment system. The company, formerly known as GameNow.net Limited, was founded in 1999 and is headquartered in Shanghai, China with additional offices in Beijing, Chengdu, Nanjing, Shenyang, Wuhan, and Xi'an, China. With 27.59 million shares outstanding and 3.17 million shares declared short as of July 2008, there is a failure to deliver in shares of NCTY. According to quarterly data provided by the SEC, there were still 36,720 shares of NCTY that were failing-to-deliver as of September 19, 2007.

NetLogic Microsystems Inc. (NASDAQ: NETL | Quote | Chart | News | PowerRating) a fabless semiconductor company, designs, develops, and markets processors and integrated circuits. The company offers knowledge-based processors, physical layer products, and network search engine products for systems used in the Internet infrastructure, including the enterprise, metro, access, edge, and core networking markets. Its products are deployed in routers, switches, wireless infrastructure equipment, network security appliances, datacenter servers, network access equipment, and network storage devices to accelerate the delivery of voice, video, data, and multimedia content for enterprise, datacenter, communication, and mobile wireless networks. NetLogic Microsystems sells products to original equipment manufacturers through its direct sales force and independent sales representatives primarily in the United States, Asia, and Europe. The company was founded in 1995 and is headquartered in Mountain View, California. With 21.4 million shares outstanding and 8.77 million shares declared short as of July 2008, there is a failure to deliver in shares of NETL. According to quarterly data provided by the SEC, there were still 88,151 shares of NETL that were failing-to-deliver as of September 27, 2007.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.

BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.

BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

Contact: Thomas Ronk, CEO www.buyins.net Tom@buyins.net +1-800-715-9999

CONTACT: Thomas Ronk, CEO, Buyins.net Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on BPZ Energy Inc. (BZP) click here. BPZ Energy Inc. (BZP) has Short Term PowerRatings of 6. Details on BPZ Energy Inc. (BZP) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [BZP]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.